Home › Trials › NCT06381245
Clinical trial No longer in our active list Observational Ages 18 and up

Registry for first-time ablation of atrial fibrillation

Official title: First-time Ablation of Atrial Fibrillation Registry

Run by Medical University of Warsaw · NCT06381245 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study looks at what factors can help doctors choose the right patients for their first ablation treatment for atrial fibrillation to make the procedure more successful and safer.

More Atrial Fibrillation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorMedical University of Warsaw
Academic / other
Locations1 site (Warsaw)
Trial IDNCT06381245 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with paroxysmal or persistent atrial fibrillation who are undergoing their first ablation.

Probably not a fit

Patients who are unable to give informed consent or have serious health conditions existing prior to ablation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify predictors of successful ablation in patients with atrial fibrillation (AF) by examining various clinical, electrophysiological, electrocardiographic, ultrasound, cardiac anatomy, and biomarker factors. The goal is to analyze these predictors to improve patient selection for ablation procedures, thereby increasing success rates and minimizing unnecessary risks. By tailoring therapeutic decisions based on individual patient profiles, the study seeks to enhance the overall management of AF.

Why it matters

Potential benefit: If successful, this study could lead to improved outcomes for patients undergoing ablation for atrial fibrillation by identifying the best predictors for treatment success.

How similar studies have gone: While there have been studies on predictors of ablation success, this specific approach focusing on a comprehensive set of factors is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* paroxysmal or persistent AF
* first-time ablation of AF

Exclusion Criteria:

* patients unable to give informed consent
* serious health condition existing before ablation

Where it's running

  • Medical University of Warsaw
    Warsaw, Poland     Recruiting

Study contacts

  • Principal investigator: Monika Gawałko, MD, PhD — 1st Department of Cardiology, Medical University of Warsaw
  • Study coordinator: Monika Gawałko, MD, PhD
  • Email: monika.gawalko@wum.edu.pl
  • Phone: 22 599 19 58

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Atrial Fibrillation 390Arrhythmia 79Medical University of Warsaw 45
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.